—
This report analyzes the global diabetic lancing device market by type (push button safety lancets, pressure activated safety lancets, side button safety lancets), by gauge (17/18g, 21g, 23g, 25g, 28g, 30g), by penetration depth, by end-user; it also studies the top manufacturers in the market.The global diabetic lancing device market is expected to grow at a CAGR of near about 11.0% during the forecast period 2017-2023.
The major players in global diabetic lancing device market include:
B. Braun Melsungen AG
• Terumo Corporation
• Becton Dickinson
• Sanofi
• F. Hoffmann-La Roche AG
• Bayer AG
• Novo Nordisk A S
• Eli Lilly and Company
• Owen Mumford Ltd
• Medtronic
• Ypsomed Holding AG
• Sarstedt AG & Co
• Greiner Bio One
• Abbott Laboratories
• HTL-STREFA S.A
• Improve Medical
• UltiMed, Inc.
• Allison Medical, Inc.
• Artsana S.p.a.
• VOGT MEDICAL
• Perrigo Diabetes Care
• MedExel Co., Ltd
• ARKRAY Inc.
• Simple Diagnostics
• Stat Medical
• Terumo
• Trividia Health
• Others
Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/3687530-diabetic-lancing-device-market-research-report-global-forecast-to-2023
The market revenue and share have been analyzed with respect to the following regions and countries:
Americas
North America
U.S.
Canada
South America
Europe
Western Europe
U.K.
France
Germany
Italy
Spain
Rest of Western Europe
Eastern Europe
Asia-Pacific
China
Japan
India
Australia
Republic of Korea
Rest of Asia-Pacific
The Middle East & Africa
United Arab Emirates
Saudi Arabia
Rest of Middle East & Africa
On the basis of type, the global diabetic lancing device market has been categorized into the following segments:
Push button safety lancets
• Pressure activated safety lancets
• Side button safety lancets
On the basis of gauge, the global diabetic lancing device market has been categorized into the following segments:
17/18g
• 21g
• 23g
• 25g
• 28g
• 30g
On the basis of penetration depth, the global diabetic lancing device market has been categorized into the following segments:
0.8 mm to 1.0 mm
• 1.1 mm to 1.5 mm
• 1.6 mm to 2.0 mm
• 2.1 mm to 2.5 mm
• 2.5 mm to 3.0 mm
• Others
On the basis of end user, the global diabetic lancing device market has been categorized into the following segments:
Hospitals & clinics
• Diagnostic centers & medical institutions
• Home care & home diagnostics
• Research & academic laboratories
• Others
Research Methodology
Market Research Future analysis is conducted by industry experts who offer insight into industry structure, market segmentation, technology assessment, competitive landscape (CL), and market penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories in different regions are estimated based on primary and secondary research.
Complete Report Details @ https://www.wiseguyreports.com/reports/3687530-diabetic-lancing-device-market-research-report-global-forecast-to-2023
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
…
Chapter 12 Company Profiles
12.1 HTL-STREFA S.A.
12.1.1 Company Overview
12.1.2 Business Segment Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 Becton, Dickinson And Company
12.2.1 Company Overview
12.2.2 Business Segment Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Greiner Bio One International GmbH
12.3.1 Company Overview
12.3.2 Business Segment Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Improve Medical Technology Co. Ltd
12.4.1 Company Overview
12.4.2 Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Terumo Medical Corporation
12.5.1 Company Overview
12.5.2 Business Segment Overview
12.5.3 Financial Overview
12.5.4 Key Developments
Continued…….
Contact Info:
Name: Norah Trent
Email: Send Email
Organization: Wiseguyreports
Website: https://www.wiseguyreports.com
Release ID: 501108
Google
RSS